🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of this study is to determine the effectiveness of rifabutin triple...
Status
Unknown
Location
Multiple Locations
Start Date
2021-05-01
Trial ID
NCT04652284
Treatments Being Tested
The "test and treat" strategy for treating dyspeptic patients who are H. py...
Status
Completed
Location
Anaheim Clinical Trials, LLC
Start Date
2013-11
Trial ID
NCT01980095
The aim of our study will be to assess in an open-label, multicenter, rando...
Status
Unknown
Location
Michele Barone
Start Date
2020-01-14
Trial ID
NCT04107194
Based on the current literature, investigators hypothesize that patients wi...
Status
Terminated
Location
University of Louisville
Start Date
2014-03-06
Trial ID
NCT02099240
Treatments Being Tested
The goal of this clinical trial is to learn if the 14-day susceptibility-gu...
Status
Completed
Location
National Cheng Kung University Hospital
Start Date
2022-01-01
Trial ID
NCT06687473
Treatments Being Tested
This study aims to investigate the efficacy of a 7-day genotypic resistance...
Status
Unknown
Location
Konstantopoulio-Patision General Hospital
Start Date
2019-09-01
Trial ID
NCT04090021
Rifabutin has good chemical stability and low drug resistance rate in acidi...
Status
Completed
Location
Renji Hospital, School of Medicine, Shanghai Jiao Tong University
Start Date
2021-05-07
Trial ID
NCT04879992
Treatments Being Tested
The "test and treat" strategy for treating dyspeptic patients who are H. py...
Status
Completed
Location
Research Site
Start Date
2017-06-18
Trial ID
NCT03198507
Treatments Being Tested
This is a randomized controlled clinical trial comparing treatment success ...
Status
Terminated
Location
King Dinuzulu Hospital
Start Date
2017-06-14
Trial ID
NCT03237182
Treatments Being Tested
The goal of this clinical trial is to learn if the 14-day susceptibility-gu...
Status
Completed
Location
National Cheng Kung University Hospital
Start Date
2022-08-22
Trial ID
NCT06687499
Treatments Being Tested